Switch to
More onapp

How to use scorecard? Learn more

Gland Pharma Ltd

GLAND
Health CarePharmaceuticals
MidcapWith a market cap of ₹20,716 cr, stock is ranked 212
Moderate RiskStock is 2.54x as volatile as Nifty
1,268.2510.45 (+0.83%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't faired well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹20,716 cr, stock is ranked 212
Moderate RiskStock is 2.54x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
20.96
PB RatioPB Ratio
2.89
Dividend YieldDiv. Yield
Sector PESector PE
33.09
Sector PBSector PB
4.08
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

59%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Gland Pharma is engaged in manufacturing small volume parenterals (SVPs) and contract development services.

Investor PresentationView older 

Jan 23, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

20192020202120222.132.773.604.620.450.771.001.21
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.01%

See detailed holdings

Recent EventsAll events 

Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent 
Announced OnMar 29, 2023

GLAND PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | Download

GLAND PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | Download

Updates 
Announced OnMar 29, 2023

Gland Pharma Limited has informed the Exchange regarding 'Recommendation for Appointment of Statutory Auditors of the Company'. | Download

Gland Pharma Limited has informed the Exchange regarding 'Recommendation for Appointment of Statutory Auditors of the Company'. | Download

ESOP/ESOS/ESPS 
Announced OnMar 29, 2023

Gland Pharma Limited has informed the Exchange regarding Allotment of 10600 Shares. | Download

Gland Pharma Limited has informed the Exchange regarding Allotment of 10600 Shares. | Download

See all events